The TTM2 Trial
Today, I am joined by Josef Dankiewicz and Niklas Nielsen to discuss the amazing TTM2 trial. We have seen a progression from the enthusiasm of the HACA/Bernard trials era to the new questions of TTM1 to where we are now. Well where are we now? Listen to find out!
Become an EMCrit Member
Please consider joining EMCrit to get amazing content and become a better resuscitationist.
You Need an EMCrit Membership to see this content. Login here if you already have one.
- EMCrit 373 – Mike Weinstock with another Critical Care Bounceback: “Asymptomatic Hypertension” - April 18, 2024
- EMCrit Wee – Ross Prager on 10 Heuristics for the New ICU Attending - April 13, 2024
- EMCrit 372 – FoundStab Intubation SOP - April 5, 2024
Can you address Callaway, et al and Nikishimi et al, studies in comparison. These are both restrosopective type studies, but they seem to keep popping up every time I mention TTM 1 or 2. It appears that cooling patients is ingrained in some practices and will be difficult to make a change on a wide scale.